Related Experiment Video
Updated: Jan 16, 2026

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development
Barbara Madej1, Filip Tomaszewski1, Dagmara Szmajda-Krygier1
1Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland.
Antibodies, or immunoglobulins, are crucial for immune responses and therapeutic applications. Advances in antibody production and engineering enhance their effectiveness and safety for treating various diseases.
Area of Science:
- Immunology
- Biotechnology
- Pharmacology
Background:
- Antibodies (immunoglobulins) are key components of the immune system, targeting specific molecules.
- Immunoglobulin G (IgG) is the most clinically significant antibody class.
- Antibodies are vital biological drugs for autoimmune, infectious, and neoplastic diseases.
Purpose of the Study:
- To review antibody mechanisms of action and production methods.
- To characterize different antibody types and their structural variations.
- To highlight novel antibody formats and their therapeutic potential.
Main Methods:
- Review of antibody mechanisms: FcR interactions, complement activation, direct cytotoxicity.
- Overview of antibody production techniques: hybridoma technology, phage display, transgenic systems.
- Characterization of antibody structures and modifications for improved efficacy and safety.
Main Results:
- Antibody engineering has led to reduced immunogenicity and enhanced therapeutic profiles.
- Novel antibody formats like antibody-drug conjugates, bispecific antibodies, and nanobodies offer innovative treatment strategies.
- The antibody market demonstrates significant growth, underscoring their increasing importance.
Conclusions:
- Antibodies are essential in modern medicine, with ongoing research promising more precise and safer therapies.
- Advanced antibody engineering and novel formats are revolutionizing treatment for cancer and autoimmune disorders.
- Continued development in antibody technology will drive pharmaceutical innovation and improve patient outcomes.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Drug Products: Biologics, Biosimilars and Interchangeables
Targeted Cancer Therapies
There are several types of targeted therapies against...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Microorganisms in Medicine and Therapeutics
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF